From the Guidelines
Peritoneal dialysis catheter exit site infections should be treated with intraperitoneal antibiotics, with vancomycin plus empirical gram-negative rod coverage based on local antibiogram data, as the first line of treatment. The treatment regimen should include vancomycin 20-mg/kg loading dose infused during the last hour of the dialysis session, and then 500 mg during the last 30 min of each subsequent dialysis session, along with gentamicin (or tobramycin) 1 mg/kg, not to exceed 100 mg after each dialysis session 1. This approach is supported by the clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection, which recommend empirical dosing pending culture results 1.
Key Considerations
- The choice of antibiotic should be based on local antibiogram data to ensure effective coverage of potential pathogens.
- The treatment regimen should be adjusted based on culture results when available.
- Daily exit site care with chlorhexidine or povidone-iodine cleaning and application of mupirocin or gentamicin cream to the exit site is essential to prevent further infection.
- Patients should monitor for worsening signs of infection, including increased redness, swelling, pain, or purulent discharge, which may indicate tunnel infection requiring more aggressive therapy.
Treatment Adjustments
- If the infection fails to respond to therapy, the catheter should be removed and replaced using a different tunnel and exit site 1.
- In cases of catheter-related bacteremia, the catheter should be removed if the patient remains symptomatic for more than 36 hours or if the patient is clinically unstable 1.
- Preliminary reports suggest that catheter salvage may be possible in stable asymptomatic patients without exit site or catheter tunnel tract involvement, using a combination of systemic antibiotic therapy and catheter guidewire exchange 1.
From the Research
Peritoneal Dialysis Catheter Exit Infection Treatment Antibiotics
- The treatment of peritoneal dialysis catheter exit-site infections often involves the use of antibiotics, with the specific choice depending on the causative organism and local antibiotic sensitivity profiles 2, 3.
- Empiric therapy for exit-site infections may include the use of cefazolin or vancomycin, with or without additional coverage for gram-negative organisms 3.
- Targeted therapy may involve the use of antibiotics such as gentamicin, which has been shown to be effective in preventing exit-site infections, including those caused by gram-negative organisms 2.
- The use of mupirocin, either intranasally or at the exit site, has been shown to reduce the risk of Staphylococcus aureus exit-site and tunnel infections 3, 4, 5.
- However, the emergence of mupirocin-resistant S. aureus has brought this prophylactic strategy into question, and annual surveillance for resistant organisms is recommended 4.
- In cases where exit-site infections do not respond to treatment, catheter removal and replacement may be necessary 2, 4.
Prevention of Exit-Site Infections
- Meticulous exit-site care is vital in preventing exit-site infections, and daily cleaning of the exit site with a dedicated antimicrobial soap is essential for the longevity of the peritoneal dialysis catheter 6.
- The use of antibiotic creams and disinfectant agents, such as povidone-iodine, chlorhexidine, and electrolytic chloroxidizing solutions, can help to keep resident micro-organisms inhibited and reduce the risk of exit-site infections 6.
- Prophylaxis against S. aureus, using intranasal mupirocin or exit site mupirocin, can also help to reduce the risk of exit-site infections and peritonitis 5.